X0707 D/A LIVE 0001554907 Tolero Pharmaceuticals, Inc. 2975 Executive Parkway Suite 320 Lehi UT UTAH 84043 801-285-6003 DELAWARE None None Corporation true 2011 David Bearss, Ph.D. c/o Tolero Pharmaceuticals, Inc. 2975 Executive Parkway, Suite 320 Lehi UT UTAH 84043 Executive Officer Director Promoter Dallin Anderson c/o Tolero Pharmaceuticals, Inc. 2975 Executive Parkway, Suite 320 Lehi UT UTAH 84043 Executive Officer Director Promoter Pharmaceuticals Decline to Disclose 06b true 0001554907-14-000002 2014-08-04 false true true false 0 T.R. Winston & Company, LLC 10571 T.R. Winston & Company, LLC 10571 1999 Avenue of the Starts 25th Floor Los Angeles CA CALIFORNIA 90067 CA CALIFORNIA CO COLORADO CT CONNECTICUT IL ILLINOIS MA MASSACHUSETTS NJ NEW JERSEY NY NEW YORK NC NORTH CAROLINA WI WISCONSIN false 35469236 22490179 12979057 $16,702,073 new money; $5,318,870.85 conversion of convertible promissory notes (principal and accrued interest); $469,236.07 warrants to purchase common stock false 48 0 1485706 0 false Tolero Pharmaceuticals, Inc. /s/ Dallin Anderson Dallin Anderson President 2014-12-05